首页> 外国专利> AROMATIC-CATIONIC PEPTIDES CONJUGATED TO ANTIOXIDANTS AND THEIR USE IN TREATING COMPLEX REGIONAL PAIN SYNDROME

AROMATIC-CATIONIC PEPTIDES CONJUGATED TO ANTIOXIDANTS AND THEIR USE IN TREATING COMPLEX REGIONAL PAIN SYNDROME

机译:与抗氧化剂结合的芳香阳离子肽及其在治疗复杂的区域疼痛综合征中的用途

摘要

Compositions comprising an antioxidant directed or indirectly conjugated to an aromatic-cationic peptide are provide. Said antioxidants are selected from TEMPO, Tro, PBN, AHDP, DBHP, Caf and Hem and may be conjugated to the aromatic-cationic peptide directly or indirectly via a linker to the N-terminus, C-terminus or a side chain of an amino acid residue of the aromatic-cationic peptide. In some embodiments, the aromatic-cationic peptide is 2′,6′-Dmt-D-Arg-Phe-Lys-NH2, Phe-D-Arg-Phe-Lys-NH2 or D-Arg-2′,6′-Dmt-Lys-Phe-NH2. These conjugates have increased antioxidant activity as compared to the unconjugated aromatic-cationic peptide and have utility in treating complex regional pain syndrome.
机译:提供了包含直接或间接缀合至芳族阳离子肽的抗氧化剂的组合物。所述抗氧化剂选自TEMPO,Tro,PBN,AHDP,DBHP,Caf和Hem,并且可以直接或经由与N-末端,C-末端或氨基侧链的接头间接结合至芳族阳离子肽。芳香族阳离子肽的酸残基。在一些实施方案中,芳族阳离子肽是2',6'-Dmt-D-Arg-Phe-Lys-NH 2 ,Phe-D-Arg-Phe-Lys-NH 2 或D-Arg-2',6'-Dmt-Lys-Phe-NH 2 。与未缀合的芳族阳离子肽相比,这些缀合物具有增强的抗氧化活性,并且可用于治疗复杂的局部疼痛综合征。

著录项

  • 公开/公告号US2020308220A1

    专利类型

  • 公开/公告日2020-10-01

    原文格式PDF

  • 申请/专利权人 PETER SCHILLER;IRENA BEREZOWSKA;

    申请/专利号US201615779593

  • 发明设计人 PETER SCHILLER;IRENA BEREZOWSKA;

    申请日2016-11-29

  • 分类号C07K5/02;C07K5/11;A61P25/02;

  • 国家 US

  • 入库时间 2022-08-21 11:23:11

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号